Navigation Links
Hoya Announces Fourth Quarter and Full-Year Financial Results
Date:5/7/2010

TOKYO, May 7, 2010 /PRNewswire-FirstCall/ -- HOYA Corporation today announced financial results for the fourth quarter and fiscal year ended March 31, 2010. Net sales were 104.8 billion yen for the quarter, representing an increase of 26.4% from 82.9 billion yen in the same period last year, mainly due to a recovery in orders in the main business fields such as Electro-Optics, as well as the cost-reduction achieved through structural reform.

Operating income for the fourth quarter was 17.3 billion yen compared to operating loss of 60 million yen for the same period last year. Net income for the fourth quarter was 11.8 billion yen, or 27.48 yen per share compared to net loss of 27.8 billion yen, or 64.30 yen per share of the fourth quarter last year.

For the fiscal year ended March 31, 2010, net sales fell 9.0% over the previous fiscal year to 413.5 billion yen, however, operating income was up 8.9% to 64.3 billion yen, and net income was up 50.8% to 37.8 billion yen, due to an increase in profit in the areas of Eye Care and Pentax. Earnings per share were 87.52 yen compared with 58.01 yen in the last year.

"The Company was able to increase the full-year consolidated net sales to 413.5 billion yen, exceeding 2.5 billion yen of the projected results released on February 9, 2010." said Hiroshi Suzuki, chief executive officer of HOYA. "The Eye Care segment such as eyeglass lens business remains strong and is well-positioned in the competitive market. Also a demand for glass disks exceeded our prediction."

HOYA also announced year-end dividends forecast of 35 yen per share of common stock. The annual dividend, including the interim dividends of 30 yen per share, will amount to 65 yen per share. It will be decided at the board of directors meeting in the end of May.

The full quarterly report is available in "Financial Statement" page in HOYA website Investor Relations section at: http://www.hoya.co.jp/english/

*Results are preliminary and unaudited.

*The yen amounts shown therein are rounded down to the nearest 100 million.

About Hoya Corporation

Hoya Corporation is a global technology company based in Tokyo, Japan, and the leading supplier of innovative and indispensable high-tech products and services based upon its advanced optics technologies. Hoya is active in four fields of business: (1) Eye Care - provides eyeglasses, operates retail shops for contact lenses, and makes intraocular lenses for cataract surgery; (2) Life Care - provides endoscopic system; (3) Electro-Optics - makes mask blanks and photo masks for the semiconductor devices and LCD panels, optical lenses for digital cameras, and glass memory disks for HDDs; and (4) Imaging - produces SLR/compact digital cameras, interchangeable lenses, lens modules and micro lenses. Hoya now has over 100 subsidiaries and affiliates, and employs more than 30,500 people worldwide.


'/>"/>
SOURCE Hoya Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... Alevio, LLC ( ... the 500th case using the SiCure Sacroiliac Joint Fusion System. , SiCure is ... SiCure can be implanted in either a lateral or posterior approach, and is ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... UK Ltd (Bock) announced a strategic partnership where Bock will demonstrate DuPont’s ... OPTIMASH® AD-100, has been shown to help biogas producers in the agricultural sector ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... Supplies of ... of leading experts gathered at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) ... of technetium-99m (Tc-99m), which is used in 30 to 40 million nuclear medicine procedures ...
(Date:6/27/2017)... ... June 27, 2017 , ... The recent vote by the American Medication ... gives new hope to patients and hopefully sheds new light on the way health ... an infertility expert and founding partner of Texas Fertility Center . , ...
Breaking Biology Technology:
(Date:3/22/2017)... , March 21, 2017 ... Cloud used by retailers such as 1-800-Flowers and ... platform — Product Recommendations and Replenishment. Using Optimove,s machine ... more personalized product and replenishment recommendations to their ... also on predictions of customer intent drawn from ...
(Date:3/20/2017)... , March 20, 2017 At this year,s CeBIT ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together ... is this year,s CeBIT partner country. At the largest German biometrics company ... use: fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/16/2017)... March 16, 2017 CeBIT 2017 - Against identity fraud with DERMALOG ... ... Used combined in one project, multi-biometric solutions provide a crucial contribution ... Used combined in one ... ...
Breaking Biology News(10 mins):